NCT00193661已完成2 期
A Multi-Center, Open-Label, Observational Study of Testosterone Gel (1%) in the Treatment of Adolescent Boys With Hypogonadism
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 试验地点
- 19
研究概览
简要总结
This study is to observe efficacy and safety after T-Gel 1% treatment in delayed puberty adolescents. Subjects who complete this trial may enter a 3 month extension study (UMD-01-090E).
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 13 Years 至 17 Years（Child）
- 性别
- Male
- 接受健康志愿者
- 否
入选标准
- •Primary or secondary hypogonadism or constitutional delay in growth and puberty (CDGP)
排除标准
- •Skin intolerance to alcohol or allergy to soy
- •Generalized skin disease
- •Contraindication to testosterone or androgen products
研究者
研究点 (19)
Loading locations...
相似试验
进行中（未招募）
3 期
Evaluation of Safety and Efficacy of CTX001 in Pediatric Participants With Transfusion-Dependent β-Thalassemia (TDT)Beta-ThalassemiaGenetic Diseases, InbornHematologic DiseasesHemoglobinopathiesThalassemiaNCT05356195Vertex Pharmaceuticals Incorporated16
撤回
1 期
Safety, Tolerability, and Pharmacokinetics of AMG 827 in Adolescents With AsthmaAsthmaNCT01395485Amgen
已完成
3 期
Safety and Tolerability of SPD485 in Children Aged 6-12 Diagnosed With ADHD and Previously Participated in MTS TrialsAttention Deficit Disorder With HyperactivityNCT00151957Noven Therapeutics450
已完成
3 期
Safety and Immunogenicity of Trivalent Subunit Inactivated Flu Vaccine Administered to Healthy Children and Adolescents 3 to 17 Years of AgeSeasonal InfluenzaNCT01209780Novartis Vaccines3,116
已完成
4 期
A Study to Evaluate the Efficacy and Safety of Ixazomib in Combination With Lenalidomide and Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma Initially Treated With an Injection of Proteasome Inhibitor-Based TherapyRelapsed and/or Refractory Multiple MyelomaNCT03416374Takeda45